• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Corcept Therapeutics Incorporated - Common Stock (NQ:CORT)

    45.28 -0.35 (-0.77%)
    Streaming Delayed Price Updated: 11:22 AM EST, Jan 27, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Corcept Therapeutics Incorporated - Common Stock

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    13 14 Next >
    Corcept Therapeutics Inc (NASDAQ:CORT) Fits the Affordable Growth Profile ↗
    Via Chartmill
    News headline image
    Why Did Corcept Therapeutics Stock Surge Over 14% Today? ↗
    In the ROSELLA trial, patients receiving relacorilant with nab-paclitaxel saw their risk of death drop by about 35% compared with those given the chemotherapy alone. 
    Via Stocktwits
    Stay updated with the stocks that are on the move in today's pre-market session. ↗
    Via Chartmill
    News headline image
    Overall Survival Primary Endpoint Met in Corcept’s Pivotal Phase 3 ROSELLA Trial of Relacorilant in Patients with Platinum-Resistant Ovarian Cancer
    From Corcept Therapeutics Incorporated
    Via Business Wire
    News headline image
    1 of Wall Street’s Favorite Stock for Long-Term Investors and 2 Facing Headwinds
    Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional... 
    Via StockStory
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    1 Safe-and-Steady Stock to Target This Week and 2 That Underwhelm
    Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets. 
    Via StockStory
    News headline image
    Corcept Therapeutics Incorporated Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your Rights – CORT
    From DJS Law Group
    Via Business Wire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    Corcept Insider Transaction Explained After Shares Tumble 50% in One Day ↗
    Focused on therapies for endocrine and oncologic conditions, this biotech reported significant insider selling in its latest SEC filing. 
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Scott+Scott Attorneys at Law LLP Reminds Investors of Its Investigation Into Corcept Therapeutics Incorporated (NASDAQ: CORT)
    From Scott+Scott Attorneys at Law LLP
    Via Business Wire
    News headline image
    CORCEPT ALERT: Bragar Eagel & Squire, P.C. is Investigating Corcept Therapeutics Incorporated on Behalf of Corcept Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    CORT Investors Have Opportunity to Join Corcept Therapeutics Incorporated Fraud Investigation with the Schall Law Firm
    From The Schall Law Firm
    Via Business Wire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    1 Healthcare Stock to Target This Week and 2 We Turn Down
    Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 17.2% over... 
    Via StockStory
    Topics Stocks
    News headline image
    CORCEPT THERAPEUTICS is Being Investigated for Potential Securities Law Violations - Contact Kaplan Fox &amp; Kilsheimer LLP
    Via TheNewswire.com
    News headline image
    CORCEPT THERAPEUTICS is Being Investigated for Potential Securities Law Violations - Contact Kaplan Fox & Kilsheimer LLP
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    News headline image
    Why Corcept (CORT) Stock Is Trading Lower Today
    Shares of biopharma company Corcept Therapeutics (NASDAQ:CORT) fell 4.5% in the morning session after the company’s stock faced continued selling pressure following the U.S. Food and Drug... 
    Via StockStory
    News headline image
    Kaplan Fox Reminds Investors of Corcept Therapeutics, Inc. (CORT) to an Investigation of Potential Securities Law Violations
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    News headline image
    Kaplan Fox Reminds Investors of Corcept Therapeutics, Inc. (CORT) to an Investigation of Potential Securities Law Violations
    Via TheNewswire.com
    In today's session, these stocks are experiencing unusual volume. ↗
    Via Chartmill
    News headline image
    Kaplan Fox Alerts Investors of Corcept Therapeutics, Inc. (CORT) to an Investigation of Possible Securities Law Violations
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    News headline image
    Kaplan Fox Alerts Investors of Corcept Therapeutics, Inc. (CORT) to an Investigation of Possible Securities Law Violations
    Via TheNewswire.com
    Nasdaq, S&P 500 Futures Point To Strong New-Year Open On Wall Street: Why TSLA, BIDU, SLV, STLA Are On Traders' Radar Today ↗
    Via Stocktwits
    Topics Stocks
    News headline image
    Stocks making big moves yesterday: FuelCell Energy, Corcept, and PacBio
    Check out the companies making headlines yesterday: 
    Via StockStory
    News headline image
    Kaplan Fox Announces an Investigation Into Corcept Therapeutics, Inc. (CORT) for Potential Securities Law Violations
    Via TheNewswire.com
    News headline image
    Kaplan Fox Announces an Investigation Into Corcept Therapeutics, Inc. (CORT) for Potential Securities Law Violations
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    News headline image
    Why Xeris Biopharma Stock Zoomed 7% Higher on Wednesday ↗
    One of the company's key drugs won't be challenged by a competing medication anytime soon. 
    Via The Motley Fool
    News headline image
    Why Corcept Therapeutics Plummeted by 50% Today ↗
    The final day of 2025 saw the company get a sharp "no" from a top regulator. 
    Via The Motley Fool
    News headline image
    Why Corcept (CORT) Shares Are Falling Today
    Shares of biopharma company Corcept Therapeutics (NASDAQ:CORT) fell 51.4% in the afternoon session after the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) rejecting... 
    Via StockStory
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    13 14 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.